Osteoporosis

Discharge Criteria:

  1. Patients deemed to have LOW fracture risk can be discharged with the following criteria met:
    1. Stable clinical risk factors for bone loss (not anticipated to change in the next 2-5 years)
  2. Patients deemed to have HIGH fracture risk requiring lifelong therapy (not appropriate for drug holiday) can be discharged with the following criteria met:
    1. Tolerating current osteoporosis therapy
    2. Stable BMD after 1-3 years of osteoporosis therapy
    3. No new fractures on current osteoporosis therapy
  3. Patients currently on Bisphosphonate DRUG HOLIDAY can be discharged if the following criteria are met:
    1. Completed bisphosphonate therapy for 3-6 years with adequate clinical response
    2. Prior denosumab and transitioned to bisphosphonate therapy for 12 or more months, with stable BMD 
    3. No new fractures (during osteoporosis therapy)
    4. Stable clinical risk factors for bone loss (not anticipated to change in next 2-5 years)
  4. Patient with moderate or high risk of fracture and consistently expresses a desire not to start pharmacotherapy

Resources: 

Reviewed by topic experts Lianne Tile, Angela Cheung, Robert Josse and Miranda Boggild